UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Suramin: an anticancer drug with a unique mechanism of action

Journal of clinical oncology, 1989-04, Vol.7 (4), p.499-508

1989

Volltextzugriff (PDF)

Characteristics of cell lines established from human gastric carcinoma

Cancer research (Chicago, Ill.), 1990-05, Vol.50 (9), p.2773-2780

1990

Volltextzugriff (PDF)

Circulating Glycosaminoglycan Anticoagulants Associated With Suramin Treatment

Blood, 1988-02, Vol.71 (2), p.273-279

1988

Volltextzugriff (PDF)

Phase I study of paclitaxel and day 1/day 8 gemcitabine in patients with solid malignancies

American journal of clinical oncology, 2000-08, Vol.23 (4), p.349-352

2000

Volltextzugriff (PDF)

Primary tumor cells resected from cancer patients and decorated with a novel form of CD80 protein serve as effective antigen-presenting cells for the induction of autologous T cell immune responses ex vivo

Human gene therapy, 2006-03, Vol.17 (3), p.334-346

2006

Volltextzugriff (PDF)

Use of Suramin in Treatment of Prostatic Carcinoma Refractory to Conventional Hormonal Manipulation

Urologic clinics of North America, 1991-02, Vol.18 (1), p.123-129

1991

Volltextzugriff (PDF)

Patterns of proto-oncogene expression in human glioma cell lines

Journal of neuroscience research, 1989-09, Vol.24 (1), p.97-106

1989

Volltextzugriff (PDF)

Suramin in advanced platinum-resistant ovarian cancer

European journal of cancer (1990), 1992, Vol.28 (4), p.864-866

1992

Volltextzugriff (PDF)

Effects of suramin on the function and structure of the adrenal cortex in the cynomolgus monkey

The journal of clinical endocrinology and metabolism, 1987-07, Vol.65 (1), p.153-158

1987

Volltextzugriff (PDF)

Suramin interference with transforming growth factor-β inhibition of human renal cell carcinoma in culture

The Journal of surgical research, 1992-08, Vol.53 (2), p.195-198

1992

Volltextzugriff (PDF)

Surgical management of spinal metastases: analysis of prognostic factors during a 10-year experience

Journal of neurosurgery. Spine, 2005-05, Vol.2 (5), p.564-573

2005

Volltextzugriff (PDF)

Phase II trial of carboplatin plus cetuximab for the treatment of stage IIIB/IV non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.18005-18005

2007

Volltextzugriff (PDF)

A phase II clinical trial utilizing maximum medical and surgical cytoredutive treatments for patients with metastatic colorectal cancer to the liver

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e15130-e15130

2009

Volltextzugriff (PDF)

Suppository delivery of 5-fluorouracil in rectal cancer

Annals of surgical oncology, 1996-05, Vol.3 (3), p.270-276

1996

Volltextzugriff (PDF)

A phase II trial of gefitinib monotherapy in patients with unresectable adrenocortical carcinoma (ACC)

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.15527-15527

2007

Volltextzugriff (PDF)

Outcome of elderly (≥70 years) non-small cell lung cancer (NSCLC) patients on a multicenter, phase III randomized trial comparing weekly vs. standard schedules of paclitaxel (P) plus carboplatin (C)

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.7149-7149

2005

Volltextzugriff (PDF)

Phase II study of cyclophosphamide, etoposide and estramustine in patients with androgen independent prostate cancer

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.4757-4757

2005

Volltextzugriff (PDF)

A multicenter, phase III randomized trial for stage IIIB/IV NSCLC of weekly paclitaxel and carboplatin vs. standard paclitaxel and carboplatin given every three weeks, followed by weekly paclitaxel

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.7017-7017

2004

Volltextzugriff (PDF)

High-dose (HD) irinotecan in patients with recurrent unresectable high-grade gliomas on glucoronidation-enhancing anticonvulsants (GEACs): A phase I/II study

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.1578-1578

2004

Volltextzugriff (PDF)

High-dose (HD) irinotecan in patients with recurrent unresectable high-grade gliomas on glucoronidation-enhancing anticonvulsants (GEACs): A phase I/II study

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.1578-1578

2004

Volltextzugriff (PDF)

A multicenter, phase III randomized trial for stage IIIB/IV NSCLC of weekly paclitaxel and carboplatin vs. standard paclitaxel and carboplatin given every three weeks, followed by weekly paclitaxel

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.7017-7017

2004

Volltextzugriff (PDF)

A phase II study of radiation with concomitant and then sequential temozolomide (TMZ) in patients (pts) with newly diagnosed supratentorial high grade malignant glioma (MG) who have undergone surgery with carmustine (BCNU) wafer insertion

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.1547-1547

2005

Volltextzugriff (PDF)

Combined immunochemotherapy with reduced dose whole brain radiotherapy (WBRT) for newly diagnosed patients with primary CNS lymphoma (PCNSL)

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.1518-1518

2004

Volltextzugriff (PDF)

Combined immunochemotherapy with reduced dose whole brain radiotherapy (WBRT) for newly diagnosed patients with primary CNS lymphoma (PCNSL)

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.1518-1518

2004

Volltextzugriff (PDF)

The Effect of Suramin, Tumor Necrosis Factor and Interferon γ on Human Prostate Carcinoma

The Journal of urology, 1991-02, Vol.145 (2), p.389-392

1991

Volltextzugriff (PDF)

1 – 25 von 119

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(113)
Mit Volltextzugriff
(94)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Suramin: an anticancer drug with a unique mechanism of action

Characteristics of cell lines established from human gastric carcinoma

Circulating Glycosaminoglycan Anticoagulants Associated With Suramin Treatment

Phase I study of paclitaxel and day 1/day 8 gemcitabine in patients with solid malignancies

Primary tumor cells resected from cancer patients and decorated with a novel form of CD80 protein serve as effective antigen-presenting cells for the induction of autologous T cell immune responses ex vivo

Use of Suramin in Treatment of Prostatic Carcinoma Refractory to Conventional Hormonal Manipulation

Patterns of proto-oncogene expression in human glioma cell lines

Suramin in advanced platinum-resistant ovarian cancer

Effects of suramin on the function and structure of the adrenal cortex in the cynomolgus monkey

Suramin interference with transforming growth factor-β inhibition of human renal cell carcinoma in culture

Surgical management of spinal metastases: analysis of prognostic factors during a 10-year experience

Phase II trial of carboplatin plus cetuximab for the treatment of stage IIIB/IV non-small cell lung cancer (NSCLC)

A phase II clinical trial utilizing maximum medical and surgical cytoredutive treatments for patients with metastatic colorectal cancer to the liver

Suppository delivery of 5-fluorouracil in rectal cancer

A phase II trial of gefitinib monotherapy in patients with unresectable adrenocortical carcinoma (ACC)

Outcome of elderly (≥70 years) non-small cell lung cancer (NSCLC) patients on a multicenter, phase III randomized trial comparing weekly vs. standard schedules of paclitaxel (P) plus carboplatin (C)

Phase II study of cyclophosphamide, etoposide and estramustine in patients with androgen independent prostate cancer

A multicenter, phase III randomized trial for stage IIIB/IV NSCLC of weekly paclitaxel and carboplatin vs. standard paclitaxel and carboplatin given every three weeks, followed by weekly paclitaxel

High-dose (HD) irinotecan in patients with recurrent unresectable high-grade gliomas on glucoronidation-enhancing anticonvulsants (GEACs): A phase I/II study

High-dose (HD) irinotecan in patients with recurrent unresectable high-grade gliomas on glucoronidation-enhancing anticonvulsants (GEACs): A phase I/II study

A multicenter, phase III randomized trial for stage IIIB/IV NSCLC of weekly paclitaxel and carboplatin vs. standard paclitaxel and carboplatin given every three weeks, followed by weekly paclitaxel

A phase II study of radiation with concomitant and then sequential temozolomide (TMZ) in patients (pts) with newly diagnosed supratentorial high grade malignant glioma (MG) who have undergone surgery with carmustine (BCNU) wafer insertion

Combined immunochemotherapy with reduced dose whole brain radiotherapy (WBRT) for newly diagnosed patients with primary CNS lymphoma (PCNSL)

Combined immunochemotherapy with reduced dose whole brain radiotherapy (WBRT) for newly diagnosed patients with primary CNS lymphoma (PCNSL)

The Effect of Suramin, Tumor Necrosis Factor and Interferon γ on Human Prostate Carcinoma

Suchergebnisse filtern